TY  - JOUR

T1  - The importance of adjusting for treatment crossover bias in oncology clinical trials: An analysis of the EGF104900 trial in metastatic breast cancer (mBC).

JO  - Journal of Clinical Oncology

PY  - 2013/05/20

AU  - Paracha N

AU  - Davies A

AU  - Latimer N

AU  - Parker C

AU  - Mealing S

AU  - Scott D

AU  - Padhiar A

AU  - Schulpher M

AU  - Wang Q

ED  - 

DO  - DOI: 10.1200/jco.2013.31.15_suppl.636

PB  - American Society of Clinical Oncology (ASCO)

VL  - 31

IS  - 15_suppl

SP  - 636

EP  - 636

Y2  - 2024/12/22

ER  -